|
Issue |
Title |
|
Vol 2011, No 4 (2011) |
12 Month Rankings |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 1 (2011) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 2 (2011) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 3 (2011) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 4 (2011) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 5 (2011) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 6 (2011) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 1 (2012) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 2 (2012) |
Abbott Laboratories |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 3 (2012) |
Abbott Laboratories |
Abstract
Untitled
|
Nigel Borshell, Taskin Ahmed |
|
Vol 2012, No 4 (2012) |
Abbott Laboratories |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Vol 2013, No 1 (2013) |
Abbott Laboratories |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Vol 2011, No 1 (2011) |
AstraZeneca |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 2 (2011) |
AstraZeneca |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 3 (2011) |
AstraZeneca |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 4 (2011) |
AstraZeneca |
Abstract
Untitled
|
Nigel Borshell |
|
Vol 2011, No 5 (2011) |
AstraZeneca |
Abstract
|
Nigel Borshell |
|
Vol 2011, No 6 (2011) |
AstraZeneca |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 1 (2012) |
AstraZeneca |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 2 (2012) |
AstraZeneca |
Abstract
|
Nigel Borshell |
|
Vol 2012, No 3 (2012) |
AstraZeneca |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Vol 2012, No 4 (2012) |
AstraZeneca |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Vol 2013, No 1 (2013) |
AstraZeneca |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Vol 2013, No 1 (2013) |
AstraZeneca Ramps Up Deal-Making Activity |
Abstract
|
Heather Cartwright |
|
Vol 2012, No 4 (2012) |
Bayer |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
1 - 25 of 143 Items |
1 2 3 4 5 6 > >> |